VIOMI TECHNOLOGY CO LTD-ADR (VIOT)

US92762J1034 - ADR

0.5455  +0.01 (+1.02%)

Fundamental Rating

2

Taking everything into account, VIOT scores 2 out of 10 in our fundamental rating. VIOT was compared to 68 industry peers in the Household Durables industry. Both the profitability and financial health of VIOT have multiple concerns. VIOT does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year VIOT has reported negative net income.
The reported net income has been mixed in the past 5 years: VIOT reported negative net income in multiple years.
In multiple years VIOT reported negative operating cash flow during the last 5 years.

1.2 Ratios

VIOT has a worse Return On Assets (-3.07%) than 77.61% of its industry peers.
With a Return On Equity value of -6.28%, VIOT is not doing good in the industry: 73.13% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.07%
ROE -6.28%
ROIC N/A
ROA(3y)-3.31%
ROA(5y)1.04%
ROE(3y)-6.71%
ROE(5y)2.51%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 22.84%, VIOT is doing worse than 68.66% of the companies in the same industry.
VIOT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for VIOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.11%
GM growth 5Y-4.01%

3

2. Health

2.1 Basic Checks

VIOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VIOT has less shares outstanding
Compared to 5 years ago, VIOT has about the same amount of shares outstanding.
The debt/assets ratio for VIOT is higher compared to a year ago.

2.2 Solvency

VIOT has an Altman-Z score of 1.37. This is a bad value and indicates that VIOT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VIOT (1.37) is worse than 77.61% of its industry peers.
VIOT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
VIOT's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. VIOT outperforms 65.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACCN/A
WACC8.92%

2.3 Liquidity

VIOT has a Current Ratio of 1.80. This is a normal value and indicates that VIOT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.80, VIOT is doing worse than 67.16% of the companies in the same industry.
VIOT has a Quick Ratio of 1.45. This is a normal value and indicates that VIOT is financially healthy and should not expect problems in meeting its short term obligations.
VIOT's Quick ratio of 1.45 is fine compared to the rest of the industry. VIOT outperforms 70.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.45

3

3. Growth

3.1 Past

VIOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.92%, which is quite impressive.
Looking at the last year, VIOT shows a very negative growth in Revenue. The Revenue has decreased by -22.87% in the last year.
VIOT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.54% yearly.
EPS 1Y (TTM)68.92%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q71.67%
Revenue 1Y (TTM)-22.87%
Revenue growth 3Y-24.64%
Revenue growth 5Y-0.54%
Revenue growth Q2Q30.59%

3.2 Future

Based on estimates for the next years, VIOT will show a small growth in Earnings Per Share. The EPS will grow by 5.72% on average per year.
The Revenue is expected to grow by 12.13% on average over the next years. This is quite good.
EPS Next Y-27.45%
EPS Next 2Y5.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.62%
Revenue Next 2Y12.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

VIOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VIOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VIOT!.
Industry RankSector Rank
Dividend Yield N/A

VIOMI TECHNOLOGY CO LTD-ADR

NASDAQ:VIOT (4/18/2024, 7:26:39 PM)

0.5455

+0.01 (+1.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap37.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.07%
ROE -6.28%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.8
Quick Ratio 1.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)68.92%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-27.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-22.87%
Revenue growth 3Y-24.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y